3,4-Di(cyclopropylmethoxy) Roflumilast
| Product Name | 3,4-Di(cyclopropylmethoxy) Roflumilast |
|---|---|
| Alternate Names | Roflumilast Impurities, Impurities of Roflumilast |
| CAT No. | CS-T-17885 |
| CAS No. | 1391052-24-6 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 407.29 g/mol |
| Mol. For. | C₂₀H₂₀Cl₂N₂O₃ |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Roflumilast |
| Therapeutic | Anti-Asthma / COPD |
| Canonical Smiles | C1CC1COC2=C(C=C(C=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OCC4CC4 |
| InchIKey | YQDXYEVCMGROIA-UHFFFAOYSA-N |
| Inchl | InChI=1S/C20H20Cl2N2O3/c21-15-8-23-9-16(22)19(15)24-20(25)14-5-6-17(26-10-12-1-2-12)18(7-14)27-11-13-3-4-13/h5-9,12-13H,1-4,10-11H2,(H,23,24,25) |
| IUPAC | 3,4-bis(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)benzamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
3,4-Di(cyclopropylmethoxy) Roflumilast is a drug compound that is used for the treatment of chronic obstructive pulmonary disease (COPD). It is a phosphodiesterase 4 (PDE4) inhibitor that works by reducing inflammation in the lungs which can help to improve breathing and reduce symptoms of COPD.
Chemically, 3,4-Di(cyclopropylmethoxy) Roflumilast is a cyclic AMP-specific PDE4 inhibitor. It is a white or off-white powder that is soluble in methanol and ethanol.
The recommended dosage of 3,4-Di(cyclopropylmethoxy) Roflumilast is 500 micrograms once daily. It is generally recommended for use in patients with severe COPD and a history of exacerbations.
Common side effects associated with the use of 3,4-Di(cyclopropylmethoxy) Roflumilast include nausea, diarrhea, headache, and insomnia. Patients with a history of depression or suicidal thoughts should be monitored closely while taking this medication.
Overall, 3,4-Di(cyclopropylmethoxy) Roflumilast is an effective medication for the treatment of COPD. It is important to follow the recommended dosage and to be aware of potential side effects when using this medication.
Get an Instant Quote
Related Compounds
Roflumilast Impurity 9 | deschloro bromo Roflumilast | Roflumilast Impurity 7 | Roflumilast difluoromethoxybenzoate | Roflumilast Impurity 4 | Roflumilast N-oxide | Roflumilast Dimer | Roflumilast Impurity 8 |